Founders Financial Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-10,379
| Closed | -$960K | – | 259 |
|
2021
Q2 | $960K | Sell |
10,379
-1,603
| -13% | -$148K | 0.19% | 108 |
|
2021
Q1 | $1.06M | Buy |
11,982
+221
| +2% | +$19.6K | 0.25% | 84 |
|
2020
Q4 | $1.1M | Buy |
11,761
+1,854
| +19% | +$173K | 0.26% | 68 |
|
2020
Q3 | $631K | Buy |
9,907
+5,559
| +128% | +$354K | 0.2% | 75 |
|
2020
Q2 | $227K | Buy |
+4,348
| New | +$227K | 0.07% | 149 |
|
2019
Q4 | – | Sell |
-8,183
| Closed | -$242K | – | 122 |
|
2019
Q3 | $242K | Sell |
8,183
-4,201
| -34% | -$124K | 0.08% | 119 |
|
2019
Q2 | $427K | Buy |
12,384
+3,232
| +35% | +$111K | 0.14% | 88 |
|
2019
Q1 | $301K | Buy |
+9,152
| New | +$301K | 0.1% | 99 |
|